46 results
424B3
AKTS
Akoustis Technologies Inc
23 May 24
Prospectus supplement
5:35pm
the minimum requirements for continued listing on the Nasdaq Capital Market, the impact of a pandemic or epidemic or natural disaster, including … the COVID-19 pandemic, the Russian-Ukrainian and Middle East conflicts and other sources of volatility on our operations, financial condition
424B5
AKTS
Akoustis Technologies Inc
23 May 24
Prospectus supplement for primary offering
5:12pm
Capital Market, the impact of a pandemic or epidemic or natural disaster, including the COVID-19 pandemic, the Russian-Ukrainian and Middle East
8-K
EX-99.1
AKTS
Akoustis Technologies Inc
22 May 24
Akoustis Completes Rollout of its XBAW® Design Updates
5:20pm
listing on the Nasdaq Capital Market, the impact of a pandemic or epidemic or natural disaster, including the COVID-19 pandemic, the Russian-Ukrainian
8-K
EX-99.2
AKTS
Akoustis Technologies Inc
22 May 24
Akoustis Completes Rollout of its XBAW® Design Updates
5:20pm
integration efforts and strain on management time and resources; the impact of a pandemic or epidemic or a natural disaster, including the COVID-19 pandemic
8-K
EX-99.1
w2lsy58
13 May 24
Akoustis Reports Third Quarter FY24 Results
7:34am
8-K
EX-99.1
ud68e
13 Feb 24
Akoustis Reports Second Quarter FY24 Results
7:08am
8-K
EX-99.1
94ls8lv944 9y
29 Jan 24
Akoustis Announces Pricing of Public Offering of $10.0 Million of Common Stock
4:21pm
8-K
EX-99.2
zcy4ms k0i1rngha
29 Jan 24
Akoustis Announces Pricing of Public Offering of $10.0 Million of Common Stock
4:21pm
8-K
EX-99.2
wu6em7m6egg13ld
24 Jan 24
Selected Preliminary Financial Results for Second Quarter of Fiscal 2024
4:51pm
8-K
EX-99.1
rfs6li9 y0
13 Nov 23
Akoustis Reports First Quarter FY24 Results
7:36am
8-K
EX-99.1
rxu21mpt fsu
6 Sep 23
Results of Operations and Financial Condition
7:08am
8-K
EX-99.1
znb5vgi1dkybdnwss
9 May 23
Akoustis Reports Sixth Consecutive Quarter of Record Revenue with Third Quarter Fiscal 2023 Sales Growing over 160% Year-Over-Year
5:01pm